{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:51:39Z","timestamp":1780498299886,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sub-Optimal deployment of Self expanding interwoven stents (Supera) has been shown to increase the rate of Clinically Driven Target Lesion Revascularization (CD-TLR). Meanwhile, drug coated balloons (DCB) have been shown to reduce CD-TLR in the femoral-popliteal segment in de- novo and restenotic lesions. However, the clinical effects of vessel preparation with DCB in nominal, compressed, and elongated Supera has not been widely studied. The purpose of this study is to assess the outcomes of clinically driven re-intervention, major amputations, and mortality in relation to the use of DCB as vessel preparation in different deployment conditions (nominal, compressed, elongated) of the Supera stent. Patient chart data was collected at a single center hospital between March 2015 and May 2020. All patients were adults (\u2265\u200918\u00a0years old) and were treated with at least one (\u2265\u20091) Supera stent. Deployment status was extrapolated from anonymized angiograms. The primary endpoint of this study was CD-TLR. Secondary endpoints included amputation and mortality rates associated with each deployment condition. A total of 670 limbs were treated and patients were followed for 36\u00a0months. Nominal stent deployment was observed in 337 limbs, followed by elongated condition (n\u2009=\u2009176), then by compressed conditions (n\u2009=\u2009159). CD-TLR was observed most frequently with elongated deployment. Drug coated balloons were used as vessel prep prior to stenting and showed a protective effect regardless of deployment status; O.R\u2009=\u20090.44 (CI 0.30\u20130.66, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05).<\/jats:p>","DOI":"10.1038\/s41598-022-25634-z","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T13:07:24Z","timestamp":1670591244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug coated balloon improves outcomes of sub-optimal Supera deployment in the intermediate term"],"prefix":"10.1038","volume":"12","author":[{"given":"Prakash","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriya","family":"Avadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"25634_CR1","volume-title":"Update on Endovascular Treatment of Peripheral Vascular Disease: New Tools, Techniques, and Indications","author":"Z Krajcer","year":"2000","unstructured":"Krajcer, Z. & Howell, M. H. Update on Endovascular Treatment of Peripheral Vascular Disease: New Tools, Techniques, and Indications (Published online, 2000)."},{"issue":"5","key":"25634_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1526602815592206","volume":"22","author":"MR Jaff","year":"2015","unstructured":"Jaff, M. R. et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). J. Endovasc. Ther. 22(5), 663\u2013677. https:\/\/doi.org\/10.1177\/1526602815592206 (2015).","journal-title":"J. Endovasc. Ther."},{"issue":"2","key":"25634_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/J.JVS.2019.05.034","volume":"71","author":"A Mohapatra","year":"2020","unstructured":"Mohapatra, A. et al. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries. J. Vasc. Surg. 71(2), 560. https:\/\/doi.org\/10.1016\/J.JVS.2019.05.034 (2020).","journal-title":"J. Vasc. Surg."},{"issue":"18","key":"25634_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMOA051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger, M. et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N. Engl. J. Med. 354(18), 1879\u20131888. https:\/\/doi.org\/10.1056\/NEJMOA051303 (2006).","journal-title":"N. Engl. J. Med."},{"key":"25634_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/VHRM.S246528","volume":"16","author":"S Giannopoulos","year":"2020","unstructured":"Giannopoulos, S. et al. Sex-related differences in the outcomes of endovascular interventions for chronic limb-threatening ischemia: results from the liberty 360 study. Vasc. Health Risk Manag. 16, 271\u2013284. https:\/\/doi.org\/10.2147\/VHRM.S246528 (2020).","journal-title":"Vasc. Health Risk Manag."},{"key":"25634_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S70229","author":"K Bishu","year":"2015","unstructured":"Bishu, K. & Armstrong, E. J. Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence. Vasc. Health Risk Manag. https:\/\/doi.org\/10.2147\/VHRM.S70229 (2015).","journal-title":"Vasc. Health Risk Manag."},{"key":"25634_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27058","author":"LA Garcia","year":"2017","unstructured":"Garcia, L. A. et al. SUPERB final 3-year outcomes using interwoven nitinol biomimetic Supera stent. Catheter. Cardiovasc. Interv. https:\/\/doi.org\/10.1002\/ccd.27058 (2017).","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"21","key":"25634_CR8","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/J.JACC.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird, J. R. et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J. Am. Coll. Cardiol. 66(21), 2329\u20132338. https:\/\/doi.org\/10.1016\/J.JACC.2015.09.063 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"25634_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","volume":"136","author":"P Krishnan","year":"2017","unstructured":"Krishnan, P. et al. Stellarex drug-coated balloon for treatment of femoropopliteal disease: 12-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation 136(12), 1102\u20131113. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028893 (2017).","journal-title":"Circulation"},{"key":"25634_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1406235","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield, K. et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/nejmoa1406235 (2015).","journal-title":"N. Engl. J. Med."},{"key":"25634_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.AVSG.2019.06.038","volume":"62","author":"EM San Norberto","year":"2020","unstructured":"San Norberto, E. M., Flota, C. M., Fidalgo-Domingos, L., Taylor, J. H. & Vaquero, C. Real-world results of supera stent implantation for popliteal artery atherosclerotic lesions: 3-year outcome. Ann Vasc Surg. 62, 397\u2013405. https:\/\/doi.org\/10.1016\/J.AVSG.2019.06.038 (2020).","journal-title":"Ann Vasc Surg."},{"key":"25634_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1526602817725062","author":"SW de Boer","year":"2017","unstructured":"de Boer, S. W. et al. Short-term Results of the RAPID randomized trial of the legflow paclitaxel-eluting balloon with Supera stenting versus Supera stenting alone for the treatment of intermediate and long superficial femoral artery lesions. J. Endovasc. Ther. https:\/\/doi.org\/10.1177\/1526602817725062 (2017).","journal-title":"J. Endovasc. Ther."},{"issue":"5","key":"25634_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/J.CARREV.2017.11.007","volume":"19","author":"H Bhatt","year":"2018","unstructured":"Bhatt, H., Kovach, R., Janzer, S. & George, J. C. SUPERA stent outcomes in above-the-knee interventions: effects of COMPression and ELongation (SAKE-COMPEL) sub-study. Cardiovasc. Revasculariz. Med. 19(5), 512\u2013515. https:\/\/doi.org\/10.1016\/J.CARREV.2017.11.007 (2018).","journal-title":"Cardiovasc. Revasculariz. Med."},{"issue":"20","key":"25634_CR14","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/J.JCIN.2017.08.027","volume":"10","author":"K Niazi","year":"2017","unstructured":"Niazi, K. & Tukaye, D. N. Challenges of stent restenosis in superficial femoral and popliteal artery disease. JACC Cardiovasc. Interv. 10(20), 2124\u20132125. https:\/\/doi.org\/10.1016\/J.JCIN.2017.08.027 (2017).","journal-title":"JACC Cardiovasc. Interv."},{"issue":"6","key":"25634_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.23736\/S0021-9509.19.11109-3","volume":"60","author":"SW de Boer","year":"2019","unstructured":"de Boer, S. W. et al. Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID Trial. J. Cardiovasc. Surg. (Torino) 60(6), 679\u2013685. https:\/\/doi.org\/10.23736\/S0021-9509.19.11109-3 (2019).","journal-title":"J. Cardiovasc. Surg. (Torino)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25634-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T13:09:19Z","timestamp":1670591359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25634-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25634-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21327"}}